Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

Rock Creek Pharmaceuticals Discloses Further Anatabine Patent Filing

September 20, 2011 By Bio-Medicine.Org

GLEN ALLEN, Va., Sept. 20, 2011 /PRNewswire/ — Rock Creek
Pharmaceuticals, a subsidiary of Star Scientific, Inc. (NASDAQ:
CIGX), announced that on September 19, 2011 a utility patent
application was filed with the Patent and Trademark Office (“PTO”).
This utility patent application is based on several
previously-filed provisional applications, and it is directed to
various products containing anatabine and the administration of
anatabine to reduce inflammation. Anatabine has the potential to be
particularly useful for nutritional support for disorders involving
inflammation that is associated with Nuclear Factor-KappaB (NF-kB)
mediated transcription. NF-kB is a transcription factor that
operates in cells and participates in the immune response. NF-kB
mediated transcription is associated with numerous disorders,
including those with inflammatory components, abnormal immune
response and/or inappropriate cell proliferation.  NF-kB is
associated with over 200 inflammatory pathways.

(Logo:
http://photos.prnewswire.com/prnh/20090317/STARSCIENTIFICLOGO)

Rock Creek Pharmaceuticals has developed a dietary supplement,
Anatabloc™, that contains anatabine citrate as well as
Vitamins A & D3, which was launched on August 30. This is the
second dietary supplement developed by the company: CigRx®, the
first product, was introduced in August, 2010. CigRx® is a
non-nicotine, non-tobacco alternative for smokers that reduces the
urge to light a cigarette, and it contains both anatabine citrate
and yerba mate. It is believed that this combination of dietary
ingredients mimics the brain activity that occurs when nicotine is
inhaled. It is available for purchase via a dedicated product
website (www.cigrx.com) or the Amazon.com
purchase portal. CigRx also is available at all CVS-Pharmacy stores
in the Richmond, VA area, and in roug

‘/>”/>

SOURCE

Related Articles Read More >

Blackrock's Utah array is a miniature array of electrodes for sensing brain signals
Blackrock Neurotech and Pitt work on first at-home BCI system for remote trials
DeepWell Digital Therapeutics Mike Wilson Ryan Douglas
How DeepWell is developing video games as tools for treating medical conditions
A woman with a small, handheld device in her lap with tubes that look like earphones plugged into her ears.
Ear-puffing device for migraine treatment wins FDA breakthrough designation
Abbott
Abbott launches upgraded digital health app for neurostimulation

DeviceTalks Weekly.

July 1, 2022
Boston Scientific CEO Mike Mahoney on building a corporate culture that drives high growth results
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech 100 Index
  • Medical Tubing + Extrusion
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media LLC. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech